Slovenia has approved the Phase I/II GAIN-CTNNB1 clinical trial, representing a significant step in the treatment of a rare genetic disorder, CTNNB1 syndrome. The study will be conducted at the Univer...
Slovenia Approves Clinical Trial of Gene Therapy for Rare CTNNB1 Syndrome